CoChat

Clinical and Lifestyle-Related Prognostic Indicators among Esophageal Adenocarcinoma Patients Receiving Treatment at a Comprehensive Cancer Center

Open access

The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index; 1 of the 26 sources its claims cite were checked for support.

Abstract

Purpose: The incidence of esophageal adenocarcinoma (EAC) has risen substantially in recent decades, while the average 5-year survival remains only ~20%. Disease stage and treatment are the strongest prognostic factors. The role of lifestyle factors in relation to survival remains uncertain, with a handful of studies to date investigating associations with obesity, smoking, physical activity, diet, or medications. Methods: This study included patients diagnosed with primary adenocarcinoma of the esophagus, gastroesophageal junction, or cardia (N = 371) at Roswell Park Comprehensive Cancer Center between 2003 and 2019. Leveraging extensive data abstracted from electronic medical records, epidemiologic questionnaires, and a tumor registry, we analyzed clinical, behavioral, and environmental exposures and evaluated stage-specific associations with survival. Survival distributions were visualized using Kaplan–Meier curves. Cox proportional hazards regression models adjusted for age, sex, stage, treatment, and comorbidities were used to estimate the association between each exposure and all-cause or cancer-specific mortality. Results: Among patients presenting with localized/regional tumors (stages I–III), current smoking was associated with increased overall mortality risk (HR = 2.5 [1.42–4.53], p = 0.002), while current physical activity was linked to reduced risk (HR = 0.58 [0.35–0.96], p = 0.035). Among patients with stage IV disease, individuals reporting pre-diagnostic use of statins (HR = 0.62 [0.42–0.92], p = 0.018) or NSAIDs (HR = 0.61 [0.42–0.91], p = 0.016) had improved overall survival. Exploratory analyses suggested that high pre-diagnostic dietary consumption of broccoli, carrots, and fiber correlated with prolonged overall survival in patients with localized/regional disease. Conclusion: Our data suggest that lifestyle exposures may be differentially associated with EAC survival based on disease stage. Future investigation of larger, diverse patient cohorts is essential to validate these findings. Our results may help inform the development of lifestyle-based interventions to improve EAC prognosis and quality of life.

Overview

CoChat Summary

## TL;DR

This retrospective cohort study of 371 esophageal adenocarcinoma patients at Roswell Park found that survival associations differed by stage: current smoking and current inactivity were linked to worse outcomes in localized/regional disease, while pre-diagnostic statin and NSAID use were linked to better survival in stage IV disease. Exploratory analyses also suggested better survival with higher intake of broccoli, carrots, and fiber among localized/regional cases.

## Key findings

  • Among patients with localized/regional disease (stage I–III), current smokers had a 2.5-fold higher all-cause mortality risk than never smokers (HR = 2.5, 95% CI 1.42–4.53; p = 0.002).
  • In localized/regional disease, current physical activity was associated with lower all-cause mortality risk (HR = 0.58, 95% CI 0.35–0.96; p = 0.035).
  • Among stage IV patients, pre-diagnostic statin use was associated with lower all-cause mortality (HR = 0.62, 95% CI 0.42–0.92; p = 0.018), and pre-diagnostic NSAID use was also associated with lower all-cause mortality (HR = 0.61, 95% CI 0.42–0.91; p = 0.016).
  • Exploratory dietary analyses in localized/regional disease found reduced all-cause mortality with >3 servings/month of broccoli and carrots, and with >18.6 g/day of fiber; the paper reports 47% and 62% reduced risk for broccoli and carrots, respectively, and 66% reduced risk for higher fiber intake.

## Methods

  • Retrospective cohort of 371 patients with newly diagnosed histologically confirmed primary adenocarcinoma of the esophagus, gastroesophageal junction, or cardia, treated at Roswell Park Comprehensive Cancer Center; participants enrolled in the DBBR between January 2003 and September 2019.
  • Data came from electronic medical records, the Roswell Park Tumor Registry, and DBBR questionnaires; outcomes were all-cause survival and esophageal cancer-specific survival through September 2019.
  • Kaplan–Meier curves and Cox proportional hazards models were used, with multivariable adjustment for age, sex, stage, treatment, and comorbidities; analyses were stratified into localized/regional (stages I–III) and advanced/metastatic (stage IV) disease.

## Limitations

  • The paper states that exposure ascertainment from the EMR and questionnaire is subject to measurement error, recall bias, inaccuracies in records, and abstraction errors.
  • It notes possible selection bias because DBBR participation was voluntary, and limited generalizability because most patients were White and treated at a comprehensive cancer center.
  • The paper also states that lack of post-diagnostic information (for example, weight change, smoking cessation, physical activity, diet, and medications) may have caused residual confounding.
  • Evident from the text: some exposure data were available only for subsets of participants, including physical activity for 173 participants and dietary analysis restricted to localized/regional tumors, which limits precision and completeness.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3390/cancers13184653

Cites

58 of 58 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Study population and inclusion criteria.
Figure 1 Study population and inclusion criteria.CC BY · PubMed Central
Figure 2 Kaplan–Meier survival curves for overall survival. (A) By smoking status at diagnosis. (B) By current physical activity. Localized/regional tumors (left); advanced/metastatic tumors (right).
Figure 2 Kaplan–Meier survival curves for overall survival. (A) By smoking status at diagnosis. (B) By current physical activity. Localized/regional tumors (left); advanced/metastatic tumors (right).CC BY · PubMed Central

Verification

Claims the paper makes

1 Valid · 1 Not valid · 9 Not checked · 33 Own results and interpretations

20 more claims

Create a free account to see all 44 claims and to verify the 25 references still open.

See all claims — free account
  • Probably not a substantial claim. 9
  • The quote only partly states this claim. 7
  • It may state two separate claims as one. 3

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 58 references

Research works printed but not linked: 1

  1. Rosen, R.D., and Sapra, A. (2021, January 06). TNM Classification, StatPearls [Internet], Available online: https://www.ncbi.nlm.nih.gov/books/NBK553187/.

Cited by

See all 8

Metadata

Authors
Dighe, S. G., Yan, L., Mukherjee, S., McGillicuddy, C. S., Hulme, K. L., Hochwald, S. N., Yendamuri, S., Bain, A. J., Robillard, K. T., Moysich, K. B., Ambrosone, C. B., Millen, A. E., & Buas, M. F.
Affiliations
  • Roswell Park Comprehensive Cancer Center (US)
  • University at Buffalo, State University of New York (US)
Corresponding author
  • Dighe, Shruti G.
  • Buas, Matthew F.
Venue
Cancers
Publisher
MDPI AG
Published
2021-09-16
Volume
13
Issue
18
Pages
4653
ISSN
2072-6694 (ISSN-L)
OpenAlex
W3200933658
Cited by
8
References
58
Citations by year
2025: 1 · 2024: 1 · 2023: 5 · 2022: 1
FWCI
1.64
Type
journal article
Language
en
Open access
Locations
  • Cancers (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
National Cancer Institute (P30CA016056)
Topics
  • Health Sciences › Medicine › Surgery › Esophageal Cancer Research and Treatment
  • Health Sciences › Medicine › Oncology › Gastric Cancer Management and Outcomes
  • Health Sciences › Medicine › Otorhinolaryngology › Head and Neck Cancer Studies
Keywords
esophageal adenocarcinoma, gastroesophageal junction cancer, gastric cardia cancer, prognostic factors, survival, lifestyle factors, smoking, physical activity, statins, nonsteroidal anti-inflammatory drugs, dietary fiber, broccoli, carrot, disease stage, cancer-specific mortality, all-cause mortality

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.